Targeted inhibition of STATs and IRFs as a novel treatment strategy in cardiovascular disease

We are glad to inform you, that Professor Hans Bluyssen, the head of our Department, has received a research grant form NCN:┬áTargeted inhibition of STATs and IRFs as a novel treatment strategy in cardiovascular disease.